CHPF antibody (AA 327-354)

Catalog No. ABIN652988

The Rabbit Polyclonal anti-CHPF antibody has been validated for WB, FACS and IHC (p). It is suitable to detect CHPF in samples from Human and Mouse.

Quick Overview for CHPF antibody (AA 327-354) (ABIN652988)

Target: CHPF (Chondroitin Polymerizing Factor (CHPF))

Reactivity: Human, Mouse

Host: Rabbit

Clonality: Polyclonal

Conjugate: This CHPF antibody is un-conjugated

Application: Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: RB23131

Product Details anti-CHPF Antibody

Binding Specificity: AA 327-354

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen: This CHPF antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 327-354 amino acids from the Central region of human CHPF.

Isotype: Ig Fraction

Application Details

Application Notes: WB: 1:1000. IHC-P: 1:50~100. FC: 1:10~50

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.

Expiry Date: 6 months

Target Details for CHPF

Target: CHPF (Chondroitin Polymerizing Factor (CHPF))

Alternative Name: CHPF

Background: CHPF is a protein that has both beta-1,3-glucuronic acid and beta-1,4-N-acetylgalactosamine transferase activity. Transfers glucuronic acid (GlcUA) from UDP-GlcUA and N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of the elongating chondroitin polymer.

Molecular Weight: 85467

Gene ID: 79586

NCBI Accession: NP_001182660, NP_078812

UniProt: Q8IZ52

Pathways: Glycosaminoglycan Metabolic Process, SARS-CoV-2 Protein Interactome